DEUTSCHE BANK AG\ - ONCOLYTICS BIOTECH INC ownership

ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 20 filers reported holding ONCOLYTICS BIOTECH INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ONCOLYTICS BIOTECH INC
ValueSharesWeighting
Q1 2021$29,000
+1350.0%
7,600
+1410.9%
0.00%
Q4 2019$2,000
-71.4%
503
-96.2%
0.00%
Q3 2019$7,0000.0%13,280
+188.6%
0.00%
Q2 2019$7,000
-53.3%
4,601
-44.9%
0.00%
Q1 2019$15,000
+650.0%
8,350
+542.3%
0.00%
Q4 2018$2,000
-98.4%
1,300
-95.9%
0.00%
Q3 2018$123,000
+324.1%
32,017
+491.0%
0.00%
Q2 2018$29,0005,4170.00%
Other shareholders
ONCOLYTICS BIOTECH INC shareholders Q2 2019
NameSharesValueWeighting ↓
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 173,511$241,0000.04%
Advisor Resource Council 100,000$139,0000.01%
BRAVE ASSET MANAGEMENT INC 20,000$28,0000.01%
Aquatic Capital Management LLC 2,600$4,0000.01%
Long Focus Capital Management, LLC 40,000$56,0000.01%
Newman Dignan & Sheerar, Inc. 13,915$19,0000.01%
Disciplined Investments, LLC 5,189$7,0000.00%
Cedar Mountain Advisors, LLC 5,651$8,0000.00%
TWO SIGMA SECURITIES, LLC 27,125$38,0000.00%
SITTNER & NELSON, LLC 1,000$1,0000.00%
View complete list of ONCOLYTICS BIOTECH INC shareholders